Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study.

Belen Pilo de la FuenteJulia SabínVictoria GalánIsrael ThuissardSusana Sainz de la MazaLucienne Costa-FrossardMayra Gómez-MorenoJudit Díaz-DíazCelia Oreja-GuevaraAlberto Lozano-RosJosé M García-DomínguezLaura BorregoLucía AyusoAndy CastroPedro SánchezVirginia Meca-LallanaCarmen MuñozIgnacio CasanovaCarlos López de SilanesHugo MartínElena Rodríguez-GarcíaCristina Andreu-VázquezRosario BlascoJuan A García-MerinoYolanda Aladronull null

Published in: CNS drugs (2020)

Our findings confirm the sustained effectiveness of DMF on the clinical and radiological activity of multiple sclerosis in a real-world setting, both in naïve patients and in those switching from other multiple sclerosis therapies.

Keyphrases

multiple sclerosis
randomized controlled trial
end stage renal disease
white matter
systematic review
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors